BSX
Boston Scientific Corporation
Healthcare
$57.15
as of May 21, 2026
Sign in to add BSX to your portfolio.
Sign inMarket cap
$84.23B
P/E (TTM)
23.7x
EPS (TTM)
$2.39
Dividend yield
—
Annual financials
| FY | Revenue | Net income | FCF | Gross margin | Op. margin | EPS (diluted) |
|---|---|---|---|---|---|---|
| 2021 | $11.89B | $1.04B | $1.32B | 62.8% | 16.2% | $0.69 |
| 2022 | $12.68B | $698.00M | $914.00M | 60.8% | 14.4% | $0.45 |
| 2023 | $14.24B | $1.59B | $1.70B | 62.0% | 15.3% | $1.08 |
| 2024 | $16.75B | $1.85B | $2.65B | 61.3% | 15.7% | $1.26 |
| 2025 | $20.07B | $2.89B | $3.66B | 69.0% | 19.8% | $1.96 |
Recent prices
| Date | Open | Close | Volume |
|---|---|---|---|
| May 21, 2026 | $56.03 | $57.15 | 12.84M |
| May 20, 2026 | $56.68 | $56.67 | 15.40M |
| May 19, 2026 | $56.47 | $56.81 | 22.60M |
| May 18, 2026 | $53.56 | $55.92 | 16.77M |
| May 15, 2026 | $54.19 | $52.68 | 14.84M |
| May 14, 2026 | $53.27 | $53.55 | 14.60M |
| May 13, 2026 | $53.27 | $53.06 | 17.99M |
| May 12, 2026 | $53.95 | $54.10 | 15.92M |
| May 11, 2026 | $53.77 | $53.37 | 21.61M |
| May 08, 2026 | $56.33 | $53.93 | 20.84M |
| May 07, 2026 | $56.84 | $56.57 | 25.54M |
| May 06, 2026 | $55.81 | $56.00 | 18.68M |
| May 05, 2026 | $57.01 | $55.98 | 12.54M |
| May 04, 2026 | $56.65 | $56.85 | 13.98M |
| May 01, 2026 | $57.93 | $56.50 | 18.31M |
| Apr 30, 2026 | $57.08 | $57.61 | 21.71M |
| Apr 29, 2026 | $57.71 | $57.15 | 20.67M |
| Apr 28, 2026 | $60.21 | $58.45 | 16.90M |
| Apr 27, 2026 | $61.21 | $59.95 | 17.64M |
| Apr 24, 2026 | $65.80 | $62.07 | 17.69M |
| Apr 23, 2026 | $65.57 | $65.69 | 31.27M |
| Apr 22, 2026 | $62.51 | $64.87 | 40.40M |
| Apr 21, 2026 | $60.74 | $59.52 | 26.85M |
| Apr 20, 2026 | $63.16 | $60.99 | 16.51M |
Profitability & balance
- ROE (TTM)
- 14.8%
- Gross margin
- 70.4%
- Operating margin
- 20.1%
- Net margin
- 17.2%
- Debt / equity
- 0.43